Antibodies, Assay Kits, Biology Cells, Brd4 Antibody, Clia Kits, Ctip Antibody, Culture Cells, DNA Testing, Enzymes, Equipments, Exosomes, Gels, Irak3 Antibody, Nmnat1 Antibody, Nse Antibody, Otx2 Antibody, Panel, PCR, Ria Kits, RNA, Setd2 Antibody, Stat5 Antibody, Trpa1 Antibody, Vector & Virus, Vitronectin Antibody

Evaluation of the diagnostic test for rapid detection of covid-19 antigen (Panbio Covid rapid test) in primary care

Goal: COVID-19 an infection requires early analysis, with PCR being the gold customary take a look at. The protocols advocate using fast antigenic assessments that require analysis in precise scientific apply. The target was to judge the diagnostic take a look at for fast antigen detection, Panbio Covid fast take a look at, in contrast with PCR, in sufferers with signs of 5 or much less days of evolution and with a high-suspicion of an infection by COVID-19 in a well being middle.
Supplies and strategies: 103 sufferers over 14 years of age who attended an city well being middle situated within the Usera District of Madrid, with high-suspicion of COVID-19 an infection, within the first 5 days of evolution from the onset of signs through the month of November 2020.
Interventions: diagnostic assessments for COVID-19 are carried out: antigen and PCR.
Outcomes: The prevalence of the illness was 24.3% based on the PCR take a look at and 17.5% based on the fast antigenic take a look at. The sensitivity was 72% (95% CI: 54.3-89.6%). The specificity was 100%. The optimistic and adverse predictive values have been 100% and 91.8% respectively. Within the bivariate evaluation, there was no relationship between signs and the presence of illness, aside from myalgias (p=0.030). The multivariate evaluation discovered a relationship between cough, dyspnea, fever, myalgia, anosmia/ageusia, and ocular signs and the presence of illness.
Conclusions: The sensitivity and specificity for the Panbio fast antigen take a look at are just like different research carried out in major care. In high-prevalence of illness and with extremely suspected signs, optimistic take a look at outcomes may be thought-about definitive, however adverse outcomes would require affirmation. Myalgia, fever, dyspnea, anosmia/ageusia, and ocular signs could also be extra associated to the presence of COVID-19.
Objetivo: La infección por covid-19 requiere un diagnóstico temprano, siendo la PCR la prueba gold estándar. Los protocolos propugnan el uso de pruebas antigénicas rápidas que precisan de evaluación en la práctica clínica actual. El objetivo fue evaluar la prueba diagnóstica de detección rápida de antígeno, Panbio Covid fast take a look at, comparada con la PCR, en los pacientes con clínica de 5 o menos días de evolución y con alta sospecha de infección por covid-19 en un centro de salud.
Materiales y métodos: Un complete de 103 pacientes mayores de 14 años que acudieron a un centro de salud urbano ubicado en el Distrito de Usera de Madrid, con alta sospecha de infección por covid-19, en los primeros 5 días de evolución desde el inicio de los síntomas durante el mes de noviembre de 2020. Como intervenciones se realizan las pruebas diagnósticas de covid-19: antígeno y PCR.
Resultados: La prevalencia de la enfermedad fue del 24,3% según la prueba PCR y del 17,5% según el take a look at antigénico rápido. La sensibilidad fue del 72% (IC al 95%: 54,3-89,6%). La especificidad fue del 100%.
Los valores predictivos positivo y negativo fueron del 100% y del 91,8%, respectivamente. En el análisis bivariante, no hubo relación entre los síntomas y la presencia de enfermedad, excepto para las mialgias (p = 0,030). En el análisis multivariado se encontró relación entre la tos, la disnea, la fiebre, las mialgias, la anosmia/ageusia y los síntomas oculares y la presencia de enfermedad.
Conclusiones: La sensibilidad y la especificidad para el take a look at de antígeno rápido Panbio son similares a otros estudios realizados en atención primaria. En prevalencia alta de enfermedad y con síntomas de alta sospecha, los resultados positivos del take a look at se pueden considerar definitivos, pero los resultados negativos requerirán confirmación. Las mialgias, la fiebre, la disnea, la anosmia/ageusia y los síntomas oculares se pueden relacionar más con la presencia de covid-19.
Key phrases: Atención Primaria de Salud; COVID-19; Diagnostic assessments; Prevalence; Prevalencia; Major well being care; Pruebas diagnósticas; Sensibilidad y especificidad; Sensitivity and specificity.
milansystem
milansystem

Reliability and validity of PSQI amongst frontline well being care staff of COVID-19 utilizing classical take a look at idea and merchandise response idea

Examine targets: The applicability of sleep-related scale in frontline medical employees of COVID-19 epidemic has not been absolutely proved, so the sleep survey outcomes lack credibility and accuracy, which brings difficulties to the steerage and remedy of frontline medical employees with sleep problems, and isn’t conducive to the prevention and management of COVID-19 epidemic. This research sought to research the reliability and validity of the Pittsburgh Sleep High quality Index (PSQI) among the many frontline medical employees preventing in opposition to COVID-19 epidemic.
Strategies: A community questionnaire survey was used to research PSQI amongst frontline medical employees who fought in opposition to COVID-19 in Wuhan from March 19 to April 15, 2020. Mixed with classical take a look at idea (CTT) and merchandise response idea (IRT), the content material validity, inner consistency, assemble validity and others of PSQI have been evaluated.
Outcomes: In accordance with CTT, content material validity, criterion validity, and assemble validity of PSQI was good. However the inner consistency was higher after the deletion of “daytime dysfunction” subscale. As for IRT, problem, differential merchandise operate and wright map carried out properly.
Conclusions: The unique PSQI confirmed acceptable applicability in frontline anti-epidemic medical employees, and its traits reasonably improved after “daytime dysfunction” subscale was eliminated.
Key phrases: COVID-19; Pittsburgh Sleep High quality Index; frontline well being care staff; validity.

Aspergillus take a look at profiles and mortality in critically-ill COVID-19 sufferers

Background The literature relating to COVID-19 related pulmonary aspergillosis (CAPA) has proven conflicting observations, together with survival of CAPA sufferers not receiving antifungal remedy and discrepancy between CAPA analysis and post-mortem findings. To realize perception into the pathophysiology of CAPA we carried out a case-control research, through which we in contrast Aspergillus take a look at profiles in CAPA sufferers and controls in relation to ICU-mortality.
Strategies A multinational case-control research, through which Aspergillus take a look at outcomes, use of antifungal remedy and mortality have been collected from critically-ill COVID-19 sufferers. Sufferers have been categorised utilizing the 2020 ECMM/ISHAM consensus case definitions.
 Outcomes 219 critically-ill COVID-19 circumstances have been analyzed, together with one confirmed, 38 possible, 19 potential CAPA circumstances, 21 Aspergillus colonized sufferers, seven sufferers solely optimistic for serum (1, 3)-ß-D-glucan (BDG), and 133 circumstances with no proof of CAPA. Mortality was 53.8% in CAPA sufferers in comparison with 24.1% in sufferers with out CAPA (p=0.001). Constructive serum galactomannan (GM) and BDG have been related to elevated mortality in comparison with serum biomarker adverse CAPA sufferers (87.5% versus 41.7%, p=0.046; 90.0% versus 42.1%, p=0.029, respectively).
For every level improve in GM or ten-point BDG serum focus, the odds of demise elevated (GM, OR 10.208, 95%CI 1.621-64.291, p=0.013; BDG, OR 1.247, 95%CI 1.029-1.511, p=0.024). 
Conclusions CAPA is a fancy illness, in all probability involving a continuum of respiratory colonization, tissue-invasion and angioinvasion. Serum biomarkers are helpful for staging CAPA illness development and, if optimistic, point out angioinvasion and a excessive chance of mortality. There’s want for a biomarker that distinguishes between respiratory tract colonization and tissue invasive CAPA illness.

 

WNT-3A Recombinant Protein

40-700 2 ug
EUR 259.25
Description: Wnt-3a belongs to the Wnt family of signaling proteins that play a key role in maintaining the integrity of embryonic and adult tissues. Expression of Wnt-3a occurs primarily along the dorsal midline across overlapping regions of the Central Nervous System (CNS). Wnt-3a signaling is essential for various morphogenetic events, including embryonic patterning, cell determination, cell proliferation, CNS development, and cytoskeletal formation. Like other members of this family, Wnt-3a contains a highly conserved lipid-modified, cysteine-rich domain that is essential for cell signaling. During a biochemical process called the canonical Wnt pathway, Wnt family members bind to and activate, seven-pass transmembrane receptors of the Frizzled family, ultimately leading to the disruption of β-catenin degradation. Intracellular accumulation of β-catenin increases translocation of the protein into the nucleus, where it binds to TCF/LEF transcription factors to promote gene expression. Lack of Wnt signaling disrupts transcriptional activation of tumor suppressor genes, and has been shown to result in neoplastic transformation, oncogenesis, and human degenerative diseases. Recombinant Murine Wnt-3a is a monomeric glycoprotein containing 334 amino acid residues. Due to glycosylation, the Murine Wnt-3a migrates at an apparent molecular weight of approximately 38.0-41.0 kDa by SDS-PAGE analysis under non-reducing conditions.

Human Protein Wnt-3a (WNT3A)

1-CSB-RP155494h
  • EUR 380.00
  • EUR 214.00
  • EUR 1309.00
  • EUR 560.00
  • EUR 873.00
  • EUR 262.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Protein Wnt-3a(WNT3A),partial expressed in E.coli

Human Protein Wnt-3a (WNT3A)

1-CSB-EP026136HU
  • EUR 437.00
  • EUR 238.00
  • EUR 1544.00
  • EUR 653.00
  • EUR 1029.00
  • EUR 296.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Protein Wnt-3a(WNT3A) expressed in E.coli

Mouse Protein Wnt-3a (Wnt3a)

1-CSB-EP026136MO
  • EUR 437.00
  • EUR 238.00
  • EUR 1544.00
  • EUR 653.00
  • EUR 1029.00
  • EUR 296.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Mouse Protein Wnt-3a(Wnt3a) expressed in E.coli

Protein Wnt-3a Antibody (Biotin)

20-abx105841
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Protein Wnt-3a Antibody (FITC)

20-abx107257
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Protein Wnt-3a (WNT3A) Antibody

abx117009-100ug 100 ug
EUR 467

Protein Wnt-3a Antibody (HRP)

20-abx108677
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Protein Wnt-3a (WNT3A) Antibody

20-abx136135
  • EUR 495.00
  • EUR 704.00
  • EUR 356.00
  • 100 ul
  • 200 ul
  • 50 ul

Protein Wnt-3a (WNT3A) Antibody

20-abx000791
  • EUR 411.00
  • EUR 592.00
  • EUR 182.00
  • EUR 314.00
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Protein Wnt-3a (WNT3A) Antibody

abx218011-100ug 100 ug
EUR 439

Protein Wnt-3a (WNT3A) Antibody

abx224220-100ug 100 ug
EUR 411

Protein Wnt-3a Polyclonal Antibody

42596-100ul 100ul
EUR 333

Wnt-C59

A8685-5 5 mg
EUR 148
Description: Wnt-C59 is a selective inhibitor of Wnt signaling with IC50 value of 74 pM [1].

Wnt Family Member 3A (WNT3A) Antibody

20-abx211813
  • EUR 411.00
  • EUR 300.00
  • 100 ul
  • 50 ul

Wnt Family Member 3A (WNT3A) Antibody

20-abx211920
  • EUR 411.00
  • EUR 300.00
  • 100 ul
  • 50 ul

Protein Wnt-3a Polyclonal Conjugated Antibody

C42596 100ul
EUR 397

Wnt Antagonist, C59

2063-5
EUR 359

Human Protein Wnt-3a(WNT3A) ELISA kit

CSB-EL026136HU-24T 1 plate of 24 wells
EUR 165
Description: Quantitativesandwich ELISA kit for measuring Human Protein Wnt-3a (WNT3A) in samples from serum, plasma. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Human Protein Wnt-3a(WNT3A) ELISA kit

1-CSB-EL026136HU
  • EUR 804.00
  • EUR 5099.00
  • EUR 2704.00
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Quantitativesandwich ELISA kit for measuring Human Protein Wnt-3a(WNT3A) in samples from serum, plasma. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Mouse Protein Wnt-3a(WNT3A) ELISA kit

CSB-EL026136MO-24T 1 plate of 24 wells
EUR 165
Description: Quantitativesandwich ELISA kit for measuring Mouse Protein Wnt-3a (WNT3A) in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Mouse Protein Wnt-3a(WNT3A) ELISA kit

1-CSB-EL026136MO
  • EUR 804.00
  • EUR 5099.00
  • EUR 2704.00
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Quantitativesandwich ELISA kit for measuring Mouse Protein Wnt-3a(WNT3A) in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Human WNT3A/ Protein Wnt-3a ELISA Kit

E2688Hu 1 Kit
EUR 571

Mouse Wnt3a/ Protein Wnt-3a ELISA Kit

E1594Mo 1 Kit
EUR 571

Human Protein Wnt-3a (WNT3A) ELISA Kit

abx570841-96tests 96 tests
EUR 668

Mouse Protein Wnt-3a (WNT3A) ELISA Kit

abx575000-96tests 96 tests
EUR 668

Chicken Protein Wnt-3a (WNT3A) ELISA Kit

abx519656-96tests 96 tests
EUR 911

Human Protein Wnt-3a (WNT3A) ELISA Kit

abx251482-96tests 96 tests
EUR 746

Mouse Protein Wnt-3a (WNT3A) ELISA Kit

abx255085-96tests 96 tests
EUR 746

ELISA kit for Mouse Protein Wnt-3a

EK4364 96 tests
EUR 553
Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse Protein Wnt-3a in samples from serum, plasma, tissue homogenates and other biological fluids.

ELISA kit for Human Protein Wnt-3a

EK4365 96 tests
EUR 553
Description: Enzyme-linked immunosorbent assay kit for quantification of Human Protein Wnt-3a in samples from serum, plasma, tissue homogenates and other biological fluids.

Mouse Wnt3a(Protein Wnt-3a) ELISA Kit

EM0737 96T
EUR 567.6
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Mus ;Sensitivity: 0.188 ng/ml

Human WNT3A(Protein Wnt-3a) ELISA Kit

EH2146 96T
EUR 567.6
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.938 ng/ml

Mouse Protein Wnt- 3a, Wnt3a ELISA KIT

ELI-06995m 96 Tests
EUR 865

Chicken Protein Wnt- 3a, WNT3A ELISA KIT

ELI-06996c 96 Tests
EUR 928

Human Protein Wnt- 3a, WNT3A ELISA KIT

ELI-06997h 96 Tests
EUR 824

5-HT-3A Antibody

34152-100ul 100ul
EUR 252

5-HT-3A Antibody

34152-50ul 50ul
EUR 187

5-HT-3A Antibody

DF3502 200ul
EUR 304
Description: 5-HT-3A Antibody detects endogenous levels of total 5-HT-3A.

5- HT- 3A Antibody

ABD3502 100 ug
EUR 438

Growth Factor Set IV, StemBoost?

K426-5
EUR 854

ELISA kit for Mouse Protein Wnt-3a (WNT3A)

KTE70008-48T 48T
EUR 332
Description: Quantitative sandwich ELISA for measuring Mouse Protein Wnt-3a (WNT3A) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Mouse Protein Wnt-3a (WNT3A)

KTE70008-5platesof96wells 5 plates of 96 wells
EUR 2115
Description: Quantitative sandwich ELISA for measuring Mouse Protein Wnt-3a (WNT3A) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Mouse Protein Wnt-3a (WNT3A)

KTE70008-96T 96T
EUR 539
Description: Quantitative sandwich ELISA for measuring Mouse Protein Wnt-3a (WNT3A) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human Protein Wnt-3a (WNT3A)

KTE60023-48T 48T
EUR 354
Description: Quantitative sandwich ELISA for measuring Human Protein Wnt-3a (WNT3A) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human Protein Wnt-3a (WNT3A)

KTE60023-5platesof96wells 5 plates of 96 wells
EUR 2252
Description: Quantitative sandwich ELISA for measuring Human Protein Wnt-3a (WNT3A) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human Protein Wnt-3a (WNT3A)

KTE60023-96T 96T
EUR 572
Description: Quantitative sandwich ELISA for measuring Human Protein Wnt-3a (WNT3A) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

Human Growth Differentiation Factor 5 (GDF-5) Antibody

30011-05111 150 ug
EUR 261

Recombinant Fibroblast Growth Factor 5 (FGF5)

4-RPA357Hu01
  • EUR 530.08
  • EUR 245.00
  • EUR 1712.80
  • EUR 637.60
  • EUR 1175.20
  • EUR 418.00
  • EUR 4132.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Fibroblast Growth Factor 5 expressed in: E.coli

Recombinant Growth Differentiation Factor 5 (GDF5)

4-RPC110Hu01
  • EUR 476.32
  • EUR 230.00
  • EUR 1511.20
  • EUR 570.40
  • EUR 1040.80
  • EUR 382.00
  • EUR 3628.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Growth Differentiation Factor 5 expressed in: E.coli

Recombinant Growth Differentiation Factor 5 (GDF5)

4-RPC110Hu02
  • EUR 485.28
  • EUR 233.00
  • EUR 1544.80
  • EUR 581.60
  • EUR 1063.20
  • EUR 388.00
  • EUR 3712.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Growth Differentiation Factor 5 expressed in: E.coli

Recombinant Growth Differentiation Factor 5 (GDF5)

4-RPC110Mu01
  • EUR 413.60
  • EUR 214.00
  • EUR 1276.00
  • EUR 492.00
  • EUR 884.00
  • EUR 340.00
  • EUR 3040.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse Growth Differentiation Factor 5 expressed in: E.coli

Mouse Growth/differentiation factor 5 (Gdf5)

1-CSB-EP009349MO
  • EUR 505.00
  • EUR 265.00
  • EUR 1827.00
  • EUR 766.00
  • EUR 1218.00
  • EUR 335.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Mouse Growth/differentiation factor 5(Gdf5) expressed in E.coli

Fibroblast Growth Factor 5 (FGF5) Antibody

20-abx128010
  • EUR 398.00
  • EUR 133.00
  • EUR 1107.00
  • EUR 537.00
  • EUR 314.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Growth Differentiation Factor 5 (GDF5) Antibody

20-abx128606
  • EUR 425.00
  • EUR 133.00
  • EUR 1177.00
  • EUR 578.00
  • EUR 328.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Growth Differentiation Factor 5 (GDF5) Antibody

20-abx109840
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Fibroblast Growth Factor 5 (FGF5) Antibody

20-abx123595
  • EUR 411.00
  • EUR 592.00
  • 100 ul
  • 200 ul

Growth Differentiation Factor 5 (GDF5) Antibody

20-abx320075
  • EUR 300.00
  • EUR 244.00
  • 100 ul
  • 50 ul

Fibroblast Growth Factor 5 (FGF5) Antibody

20-abx323550
  • EUR 314.00
  • EUR 244.00
  • 100 ug
  • 50 ug

Growth Differentiation Factor 5 (GDF5) Antibody

20-abx103263
  • EUR 425.00
  • EUR 133.00
  • EUR 1177.00
  • EUR 578.00
  • EUR 328.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Growth Differentiation Factor 5 (GDF5) Antibody

20-abx103264
  • EUR 439.00
  • EUR 133.00
  • EUR 1233.00
  • EUR 592.00
  • EUR 328.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Growth Differentiation Factor 5 (GDF5) Antibody

20-abx006710
  • EUR 411.00
  • EUR 592.00
  • EUR 182.00
  • EUR 314.00
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Fibroblast Growth Factor 5 (FGF5) Antibody

20-abx009268
  • EUR 300.00
  • EUR 439.00
  • EUR 189.00
  • 100 ul
  • 200 ul
  • 30 ul

Growth Differentiation Factor 5 (GDF5) Antibody

abx026572-400ul 400 ul
EUR 523

Growth Differentiation Factor 5 (GDF5) Antibody

abx026572-80l 80 µl
EUR 286

Growth Differentiation Factor 5 (GDF5) Antibody

abx031516-400ul 400 ul
EUR 523

Growth Differentiation Factor 5 (GDF5) Antibody

abx031516-80l 80 µl
EUR 286

Growth Differentiation Factor 5 (GDF5) Antibody

abx432738-200ul 200 ul
EUR 286

Fibroblast Growth Factor 5 (FGF5) Antibody

abx233094-100ug 100 ug
EUR 509

Growth Differentiation Factor 5 (GDF5) Antibody

20-abx176717
  • EUR 1233.00
  • EUR 592.00
  • 1 mg
  • 200 ug

Growth Differentiation Factor 5 (GDF5) Antibody

20-abx176718
  • EUR 1302.00
  • EUR 620.00
  • 1 mg
  • 200 ug

Fibroblast Growth Factor 5 (FGF5) Antibody

20-abx172410
  • EUR 787.00
  • EUR 411.00
  • 1 mg
  • 200 ug

Growth Differentiation Factor 5 (GDF5) Antibody

20-abx172684
  • EUR 718.00
  • EUR 384.00
  • 1 mg
  • 200 ug

Growth Differentiation Factor 5 (GDF5) Antibody

20-abx172685
  • EUR 913.00
  • EUR 467.00
  • 1 mg
  • 200 ug

Growth Differentiation Factor 5 (GDF5) Antibody

20-abx327566
  • EUR 314.00
  • EUR 244.00
  • 100 ug
  • 50 ug

Growth/differentiation factor 5 Polyclonal Antibody

42178-100ul 100ul
EUR 333

Epidermal Growth Factor (EGF), human recombinant

P1008-.5 500 µg
EUR 313
Description: Human epidermal growth factor (EGF) is a member of the EGF-family and plays an important role in the regulation of cell growth, proliferation, and differentiation through binding to its receptor EGFR.

Epidermal Growth Factor (EGF), human recombinant

P1008-5 5 mg
EUR 1372
Description: Human epidermal growth factor (EGF) is a member of the EGF-family and plays an important role in the regulation of cell growth, proliferation, and differentiation through binding to its receptor EGFR.

5-Hydroxytryptamine Receptor 3A (5-HT3A) Antibody

20-abx013887
  • EUR 314.00
  • EUR 98.00
  • EUR 398.00
  • EUR 495.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Wnt3a ELISA Kit| Mouse Protein Wnt-3a ELISA Kit

EF013348 96 Tests
EUR 689

Recombinant Human Protein Wnt-3a Protein, His, E.coli-100ug

QP8838-ec-100ug 100ug
EUR 408

Recombinant Human Protein Wnt-3a Protein, His, E.coli-10ug

QP8838-ec-10ug 10ug
EUR 200

Recombinant Human Protein Wnt-3a Protein, His, E.coli-1mg

QP8838-ec-1mg 1mg
EUR 1632

Recombinant Human Protein Wnt-3a Protein, His, E.coli-200ug

QP8838-ec-200ug 200ug
EUR 634

Recombinant Human Protein Wnt-3a Protein, His, E.coli-500ug

QP8838-ec-500ug 500ug
EUR 1060

Recombinant Human Protein Wnt-3a Protein, His, E.coli-50ug

QP8838-ec-50ug 50ug
EUR 263

Fetal Bovine Serum,Low IgG , < 5 ug/ml

F0710-050 500 ml
EUR 1198

5-HT-3A Conjugated Antibody

C34152 100ul
EUR 397

5-HT-3A Blocking Peptide

DF3502-BP 1mg
EUR 195

Epidermal Growth Factor Receptor Peptide (985-996)

5-01114 4 x 1mg Ask for price

Insulin-like Growth Factor I (57-70)

5-01399 4 x 5mg Ask for price

Insulin-Like Growth Factor II (69-84)

5-01400 4 x 1mg Ask for price

Platelet-Derived Growth Factor Receptor Substrate 2

5-01775 4 x 1mg Ask for price

Prepro-Nerve Growth Factor (99-115) (mouse)

5-01801 4 x 1mg Ask for price

Epidermal Growth Factor Receptor Peptide (985-996)

A1021-5 5 mg
EUR 189
Description: EGFR (epidermal growth factor receptor) exists on the cell surface and is activated by the binding of its specific ligands, including epidermal growth factor and transforming growth factor ?. EGFR dimerization stimulates its intrinsic intracellular protein-tyrosine kinase activity.